Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bacon

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Cell Reports|October 20, 2024
Dissociable contributions of the amygdala and ventral hippocampus to stress-induced changes in defensive behaviorZachary T Pennington, Alexa R LaBanca, Patlapa Sompolpong, et al.
Neurology|November 14, 2024
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic IndicationsCarson M Quinn, Prashanth Rajarajan, Alexander J Gill, et al.
Annals of Clinical and Translational Neurology|May 7, 2024
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccinationIlya Kister, Ryan Curtin, Amanda L Piquet, et al.
Nature|November 7, 2024
Offline ensemble co-reactivation links memories across daysYosif Zaki, Zachary T Pennington, Denisse Morales-Rodriguez, et al.
Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.
Annals of Clinical and Translational Neurology|September 27, 2022
Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapiesIlya Kister, Ryan Curtin, Jinglan Pei, et al.
Annals of Neurology|March 15, 2022
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational StudyIlya Kister, Yury Patskovsky, Ryan Curtin, et al.
Journal of the Neurological Sciences|April 18, 2012
Increasing age at disability milestones among MS patients in the MSBase RegistryIlya Kister, Eric Chamot, Gary Cutter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2022
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MSTomas Kalincik, Ilya Kister, Tamar E Bacon, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Cell Reports|October 20, 2024
Dissociable contributions of the amygdala and ventral hippocampus to stress-induced changes in defensive behaviorZachary T Pennington, Alexa R LaBanca, Patlapa Sompolpong, et al.
Neurology|November 14, 2024
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic IndicationsCarson M Quinn, Prashanth Rajarajan, Alexander J Gill, et al.
Annals of Clinical and Translational Neurology|May 7, 2024
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccinationIlya Kister, Ryan Curtin, Amanda L Piquet, et al.
Nature|November 7, 2024
Offline ensemble co-reactivation links memories across daysYosif Zaki, Zachary T Pennington, Denisse Morales-Rodriguez, et al.
Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.
Annals of Clinical and Translational Neurology|September 27, 2022
Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapiesIlya Kister, Ryan Curtin, Jinglan Pei, et al.
Annals of Neurology|March 15, 2022
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational StudyIlya Kister, Yury Patskovsky, Ryan Curtin, et al.
Journal of the Neurological Sciences|April 18, 2012
Increasing age at disability milestones among MS patients in the MSBase RegistryIlya Kister, Eric Chamot, Gary Cutter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2022
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MSTomas Kalincik, Ilya Kister, Tamar E Bacon, et al.
Pageof 19